Management of Diphtheria
Immediately administer diphtheria antitoxin without waiting for culture confirmation, combined with antibiotics (either benzathine penicillin or erythromycin), strict isolation, and comprehensive contact prophylaxis to prevent mortality and transmission.
Immediate Patient Management
Antitoxin Therapy - The Critical First Step
Diphtheria antitoxin must be given as soon as diphtheria is suspected clinically, before culture results are available. The antitoxin neutralizes circulating toxin but cannot reverse toxin already bound to tissues, making early administration life-saving. Obtain equine diphtheria antitoxin from the CDC (404-639-2888) or manufacturers 1. Perform sensitivity testing before administration due to the equine source, but do not delay treatment if diphtheria is strongly suspected 2.
Common Pitfall: Waiting for culture confirmation before giving antitoxin significantly increases morbidity and mortality. The toxin causes irreversible organ damage once bound to tissues.
Antibiotic Therapy
Administer antibiotics to eradicate the organism and prevent transmission, though they do not substitute for antitoxin in limiting disease severity 2. Choose either:
- Benzathine penicillin G IM: 600,000 units for children <6 years; 1,200,000 units for ≥6 years 1
- Erythromycin oral: 40 mg/kg/day for children; 1 g/day for adults for 7-10 days 1
Erythromycin may be slightly more effective, but benzathine penicillin ensures compliance with a single injection 1.
Isolation Precautions
Implement strict respiratory isolation immediately to prevent transmission through respiratory droplets. The median incubation period is only 1.4 days, and untreated cases remain colonized for an average of 18.5 days 2. Isolation must continue until:
- Clinical improvement occurs
- Two consecutive negative cultures obtained 24 hours apart after completing antibiotics
Contact Management - A Multi-Step Algorithm
Step 1: Identify Close Contacts Immediately
Close contacts include 1:
- All household members
- Persons with habitual close contact with the patient
- Anyone directly exposed to oral secretions
Do not delay contact investigation - the basic reproductive number of diphtheria is 1.7-4.3, meaning rapid secondary transmission is likely 2.
Step 2: Culture All Close Contacts
Obtain throat and nasal cultures from all close contacts regardless of vaccination status 1. This identifies asymptomatic carriers who can transmit disease (though they cause 76% fewer secondary cases than symptomatic patients) 2.
Step 3: Immediate Antimicrobial Prophylaxis
Do not wait for culture results - give all close contacts immediate chemoprophylaxis 1:
- Benzathine penicillin G IM: 600,000 units (<6 years); 1,200,000 units (≥6 years), OR
- Erythromycin oral: 40 mg/kg/day (children); 1 g/day (adults) for 7-10 days
Step 4: Daily Surveillance
Examine all close contacts daily for 7 days for signs of disease 1.
Step 5: Active Immunization
Vaccination status determines the approach 1:
- <3 doses or unknown status: Give immediate diphtheria toxoid dose and complete primary series
- ≥3 doses but not vaccinated within 5 years: Give booster dose
Critical Point: Vaccination alone cannot interrupt transmission in 72% of outbreak settings because vaccinated individuals can become colonized and transmit 2. Three doses provide 87% protection against symptomatic disease and reduce transmission by only 60% 2.
Step 6: Follow-Up for Identified Carriers
Carriers identified through cultures need 1:
- Follow-up cultures after completing antimicrobial therapy
- If still positive: Additional 10-day course of oral erythromycin
- Repeat cultures until negative
Passive Immunization for Contacts - Generally Not Recommended
Equine diphtheria antitoxin for contacts is NOT routinely recommended due to significant risks 1:
- 7% risk of immediate hypersensitivity reactions
- 5% risk of serum sickness
- No evidence of additional benefit beyond antimicrobial prophylaxis
If used (rare circumstances with impossible surveillance): 5,000-10,000 units IM after sensitivity testing, at a different site from toxoid injection 1.
Special Consideration: Cutaneous Diphtheria
Most cutaneous cases involve nontoxigenic strains. Only investigate and treat contacts if a toxigenic strain is confirmed 1. If nontoxigenic, routine contact investigation is unnecessary.
Key Evidence Nuances
The guidelines provided are from 1991 ACIP recommendations [1-1, which remain the primary authoritative source. More recent systematic review data from 2020 2 confirms the critical importance of early antitoxin administration and highlights that vaccination alone is insufficient for outbreak control, validating the comprehensive contact management approach. The combination of isolation, antibiotics, and contact prophylaxis remains essential despite vaccination because vaccinated individuals can still transmit the organism 2.
The bottom line: Diphtheria management requires aggressive, immediate action on multiple fronts simultaneously - antitoxin for the patient, antibiotics for both patient and contacts, strict isolation, and comprehensive contact tracing with prophylaxis. Delays or incomplete implementation of any component increases mortality and transmission risk.